Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Antigen delivery by dendritic cells.

¹Institute for Molecular Biology of Infectious Diseases, University of Würzburg, Röntgenring 11, D-97070 Würzburg, Germany. heidrun.moll@mail.uni-wuerzburg.de

International Journal of Medical Microbiology : IJMM

|November 10, 2004

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Inhibitory effect of phenothiazine- and phenoxazine-derived chloroacetamides on Leishmania major growth and Trypanosoma brucei trypanothione reductase.

European journal of medicinal chemistry·2015

Same author

Development of a New Antileishmanial Aziridine-2,3-Dicarboxylate-Based Inhibitor with High Selectivity for Parasite Cysteine Proteases.

Antimicrobial agents and chemotherapy·2015

Same author

Pathogen- and Host-Directed Antileishmanial Effects Mediated by Polyhexanide (PHMB).

PLoS neglected tropical diseases·2015

Same author

Antileishmanial and cytotoxic compounds from Valeriana wallichii and identification of a novel nepetolactone derivative.

Molecules (Basel, Switzerland)·2015

Same author

Cathepsin B in antigen-presenting cells controls mediators of the Th1 immune response during Leishmania major infection.

PLoS neglected tropical diseases·2014

Same author

Identification of multiple cellular uptake pathways of polystyrene nanoparticles and factors affecting the uptake: relevance for drug delivery systems.

European journal of cell biology·2014

Same journal

Successful treatment of rare non-dermatophyte onychomycosis caused by Chaetomium spp. with oral fluconazole and topical terbinafine combination - A case report from Indonesia and literature review.

International journal of medical microbiology : IJMM·2026

Same journal

Toxin gene truncation via IS1132 in non-toxigenic toxin gene-bearing (NTTB) Corynebacterium diphtheriae.

International journal of medical microbiology : IJMM·2026

Same journal

Gain-of-function mutation in the sensor kinase CpxS modulates the antimicrobial resistance and virulence of Pseudomonas aeruginosa.

International journal of medical microbiology : IJMM·2026

Same journal

Mycobacterium tuberculosis identification and antibiotic resistance gene profiling using nanopore sequencing: A new approach for tailoring more effective treatments for patients.

International journal of medical microbiology : IJMM·2026

Same journal

Epidemiology and population structure of Acinetobacter baumannii outbreak in a COVID-19 concentration center.

International journal of medical microbiology : IJMM·2026

Same journal

Herpes simplex virus 1 UL2 protein inhibits RIG-I-like receptor pathway-induced IFN-β activity by disrupting IRF3 activation.

International journal of medical microbiology : IJMM·2026

See all related articles

Dendritic cells (DCs) are key immune cells that can be harnessed for vaccination and immunotherapy against infectious diseases. DC-based strategies show promise in experimental models, with ongoing optimization for clinical use.

Area of Science:

Immunology
Vaccinology

Background:

Dendritic cells (DCs) bridge innate and adaptive immunity, orchestrating pathogen response.
DCs possess potent immunostimulatory properties valuable for immune intervention.

Purpose of the Study:

To explore the potential of dendritic cell (DC)-based strategies for vaccination and immunotherapy against infectious diseases.
To highlight recent advances in DC biology and their application in manipulating immune responses.

Main Methods:

Review of experimental systems demonstrating DC vaccination efficacy.
Discussion of ongoing optimization for DC generation, stimulation, and antigen loading.
Mention of developing in situ DC targeting methods.

Main Results:

Related Experiment Videos

DC vaccination has demonstrated protection against diverse viral, bacterial, parasitic, and fungal pathogens in experimental settings.
Advances in understanding DC biology facilitate the development of DC-based immune manipulation approaches.

Conclusions:

Dendritic cell-based vaccines represent a promising novel strategy for controlling infectious diseases.
Optimization of DC protocols and targeting methods are advancing toward clinical applications.